GI
Global Immune Technologies Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Bruhjell Jeffrey Roy, was filed 09 Dec 2013.
Global Immune Technologies Inc.: what insiders have been doing
This page follows insider dealings at Global Immune Technologies Inc. as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Global Immune Technologies Inc. The previous disclosure was published on 9 December 2013.
Over the whole record (from 2013), the tally stands at 77 purchases and no sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
77
Thresholds
n/a
Buy Volume
€195,251
77 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 9 December 2013
Declarations77 total
- 3,300,000 shares@ US$0.0197Common StockSEC:0001569959-13-000008:0Canonical exit: 3 Mar 2014 (T+90)
- 10,000 shares@ US$0.028Common StockSEC:0001577177-13-000013:0Canonical exit: 11 Nov 2013 (T+90)
- 10,000 shares@ US$0.029Common StockSEC:0001577177-13-000013:1Canonical exit: 11 Nov 2013 (T+90)
- 10,000 shares@ US$0.032Common StockSEC:0001577177-13-000013:2Canonical exit: 11 Nov 2013 (T+90)
- 10,000 shares@ US$0.0345Common StockSEC:0001577177-13-000013:3Canonical exit: 11 Nov 2013 (T+90)
- 11,000 shares@ US$0.04Common StockSEC:0001577177-13-000013:4Canonical exit: 11 Nov 2013 (T+90)
- 1,000 shares@ US$0.06Common StockSEC:0001577177-13-000012:0Canonical exit: 27 Oct 2013 (T+90)
- 2,000 shares@ US$0.05Common StockSEC:0001577177-13-000012:1Canonical exit: 30 Oct 2013 (T+90)
- 100 shares@ US$0.07Common StockSEC:0001577177-13-000012:2Canonical exit: 30 Oct 2013 (T+90)
- 1,957,943 shares@ US$0.028Common StockSEC:0001577195-13-000002:0Canonical exit: 21 Oct 2013 (T+90)
- 957,943 shares@ US$0.028Common StockSEC:0001577180-13-000012:0Canonical exit: 21 Oct 2013 (T+90)
- 12,800 shares@ US$0.055Common StockSEC:0001577180-13-000011:0Canonical exit: 16 Oct 2013 (T+90)
- 10,000 shares@ US$0.06Common StockSEC:0001577180-13-000011:1Canonical exit: 16 Oct 2013 (T+90)
- 10,000 shares@ US$0.06Common StockSEC:0001577177-13-000011:0Canonical exit: 15 Oct 2013 (T+90)
- 1,000 shares@ US$0.068Common StockSEC:0001577177-13-000010:0Canonical exit: 30 Sept 2013 (T+90)
- 10,000 shares@ US$0.06Common StockSEC:0001577177-13-000009:0Canonical exit: 25 Sept 2013 (T+90)
- 3,348 shares@ US$0.055Common StockSEC:0001577177-13-000009:1Canonical exit: 25 Sept 2013 (T+90)
- 1,000 shares@ US$0.069Common StockSEC:0001577177-13-000009:2Canonical exit: 25 Sept 2013 (T+90)
- 10,000 shares@ US$0.06Common StockSEC:0001577177-13-000009:3Canonical exit: 26 Sept 2013 (T+90)
- 10,000 shares@ US$0.065Common StockSEC:0001577177-13-000009:4Canonical exit: 26 Sept 2013 (T+90)
- 1,000 shares@ US$0.062Common StockSEC:0001577177-13-000009:5Canonical exit: 26 Sept 2013 (T+90)
- 1,000 shares@ US$0.068Common StockSEC:0001577177-13-000009:6Canonical exit: 29 Sept 2013 (T+90)
- 1,000 shares@ US$0.069Common StockSEC:0001577177-13-000008:0Canonical exit: 24 Sept 2013 (T+90)
- 10,000 shares@ US$0.056Common StockSEC:0001577180-13-000010:0Canonical exit: 23 Sept 2013 (T+90)
- 50,000 shares@ US$0.06Common StockSEC:0001577180-13-000010:1Canonical exit: 24 Sept 2013 (T+90)
25 of 77 declarations
About Global Immune Technologies Inc.
Global Immune Technologies Inc. is a company focused on developing innovative immunological solutions. It operates on the XNAS market.
